Nopoulos noted that the survey would include administering psychedelics to a cohort of men with alcohol use disorder. Half of the participants will be administered psilocybin. In contrast, the other half will get ketamine, and neither the subjects nor the researchers will know which substance is being administered.
A first-person review of the hemp-derived THC cocktail base I poured at our Cannabis Cup…
Every paper mill in the world still runs on the continuous-web design a Frenchman patented…
A new AI-assisted sci-fi satire from filmmaker Dan Levy Dagerman and the Space Weed Universe…
Spain has increased penalties for electricity theft linked to indoor cannabis cultivation after Endesa reported…
How a 52-year-old first-time grower turned trial and error into a show-stopping harvest The first…
This is the legacy knowledge drain, and it is the quiet catastrophe nobody in the…